Sign In
Buy ELV
$388.50
-2.77 (-0.708%)
At Close: Jun 18, 2026
Elevance Health Stock: Looking Beyond Near-Term Issues, I'm A Buyer
12:09pm, Friday, 18'th Oct 2024
Elevance Health's Q3 2024 results were disappointing with a significant increase in the benefit expense ratio and lowered earnings expectations for the full year. I take a close look at ELV's exposure
These Analysts Cut Their Forecasts On Elevance Health Following Q3 Earnings
11:54am, Friday, 18'th Oct 2024
Elevance Health Inc. ELV reported weaker-than-expected earnings for its third quarter on Thursday.
Elevance Health: Why Invest Over UnitedHealth Group?
11:30am, Friday, 18'th Oct 2024
Despite a disappointing Q3 report, Elevance Health remains attractive due to its relatively favorable valuation compared to UnitedHealth Group and a total shareholder yield of roughly 3.5%. Elevance's
S&P 500 Gains and Losses Today: Health Insurers Slide as Elevance Cites Medicaid Declines
06:00pm, Thursday, 17'th Oct 2024
Major U.S. equities indexes were mixed as earnings results from Taiwan Semiconductor Manufacturing (TSM) helped revitalize optimism around artificial intelligence (AI) and September retail sales data
Elevance Health: A Bad Q3 Was Almost Inevitable Given Industry Headwinds
02:30pm, Thursday, 17'th Oct 2024
Elevance Health's Q3 earnings report led to a 14% stock price drop due to increased benefit expense ratio and declining EPS. The health insurance industry faces challenges, particularly in Medicare Ad
Elevance Health's Q3 Earnings Miss Due to Medicaid Redeterminations
02:30pm, Thursday, 17'th Oct 2024
ELV's third-quarter earnings are hurt by declining membership in Medicaid and Medicare, partially offset by improved product revenues.
Why Is Elevance Health Stock Trading Lower On Thursday?
02:11pm, Thursday, 17'th Oct 2024
Elevance Health Inc. ELV reported on Thursday third-quarter revenues of $44.7 billion, up 5.3% year-over-year, beating the consensus of $43.33 billion.
Elevance Health, Inc. (ELV) Q3 2024 Earnings Call Transcript
01:13pm, Thursday, 17'th Oct 2024
Elevance Health, Inc. (NYSE:ELV ) Q3 2024 Results Conference Call October 17, 2024 8:30 AM ET Company Participants Steve Tanal - Vice President of Investor Relations Gail Boudreaux - President and CEO
3 Medical Services Stocks to Buy to Navigate Industry Challenges
12:35pm, Thursday, 17'th Oct 2024
The Zacks Medical - Services industry is growing on nursing care market growth and digital healthcare adoption. ELV, DOCS and HQY are set to gain the most.
Elevance Health earnings: Higher medical costs weigh on profits
12:26pm, Thursday, 17'th Oct 2024
CNBC's Bertha Coombs reports on Elevance Health's quarterly earnings results.
Elevance Health Stock Plunges on Profit Hit From Fall in Medicaid Memberships
10:58am, Thursday, 17'th Oct 2024
Elevance Health (ELV) shares cratered Thursday after the insurer posted a lower-than-expected profit and slashed its outlook on falling Medicaid enrollments.
Compared to Estimates, Elevance Health (ELV) Q3 Earnings: A Look at Key Metrics
10:36am, Thursday, 17'th Oct 2024
Although the revenue and EPS for Elevance Health (ELV) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with W
Elevance Health's Q3 Earnings: Profit Falls Short Of Expectations On Higher Medical Costs, Issues Soft Annual Outlook
08:36am, Thursday, 17'th Oct 2024
On Thursday, Elevance Health Inc. ELV reported third-quarter revenues of $44.7 billion, up 5.3% year-over-year, beating the consensus of $43.33 billion.
Elevance Health (ELV) Q3 Earnings Lag Estimates
08:11am, Thursday, 17'th Oct 2024
Elevance Health (ELV) came out with quarterly earnings of $8.37 per share, missing the Zacks Consensus Estimate of $9.70 per share. This compares to earnings of $8.99 per share a year ago.
Elevance Health's stock tumbles as profit dented by ‘unprecedented' Medicaid challenges
07:32am, Thursday, 17'th Oct 2024
“We remain confident in the long-term earnings potential of our diverse businesses as we navigate a dynamic operating environment and unprecedented challenges in the Medicaid business,” Chief Exec
